Statins given early decrease progression of kidney disease

May 8 2014

Pravastatin, a medicine widely used for treatment of high cholesterol, also slows down the growth of kidney cysts in children and young adults with autosomal dominant polycystic kidney disease (ADPKD), a study has shown. ADPKD is the most common potentially lethal hereditary kidney disease, affecting at least 1 in 1000 people. ADPKD is characterized by progressive kidney enlargement due to cyst growth, which results in loss of kidney function over time.

For more information read the full story here.
 

Recent News

Simon battles through the rain to raise over £2300 as others raise £1000 more
October 5 2020
Share you experience - Announcing The 2020 National Kidney Patient Survey - Kidney PREM
September 22 2020
Second online patient information meeting notes
September 20 2020
Have you shared your decision?
September 14 2020
In memory of John Roberts - former Chair & Honorary Secretary of SGKPA
September 7 2020

Join Us

Register with us, become a member and subscribe to our newsletters including the latest on the impact of coronavirus for patients at St George’s Hospital.